about
Patterns of Glaucoma Medication Adherence over Four Years of Follow-UpThe Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional SurveyGaps in Glaucoma care: A systematic review of monoscopic disc photos to screen for glaucomaThe Effect of Counseling on Cataract Patient Knowledge, Decisional Conflict, and SatisfactionSystematic Review of Educational Interventions to Improve Glaucoma Medication Adherence: an update in 2015The potential association between postmenopausal hormone use and primary open-angle glaucoma.Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration.Aberrant wound-healing response in mitomycin C-treated leaking blebs: a histopathologic study.Switching to less expensive blindness drug could save medicare part B $18 billion over a ten-year periodRisk factors associated with developing branch retinal vein occlusion among enrollees in a United States managed care plan.Eye care providers' attitudes towards tele-ophthalmologyAssociation of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus.The relationship between statin use and open-angle glaucomaWhy Patients With Glaucoma Lose Vision: The Patient Perspective.Systematic review of educational interventions to improve glaucoma medication adherence.Agreement of Ocular Symptom Reporting Between Patient-Reported Outcomes and Medical Records.Glaucoma Screening in Nepal: Cup-to-Disc Estimate With Standard Mydriatic Fundus Camera Compared to Portable Nonmydriatic Camera.Association between the use of glaucoma medications and mortality.Eye Symptom Questionnaire to Evaluate Anterior Eye Health.Telemedicine for ophthalmic consultation services: use of a portable device and layering information for graders.User-centered Design of the eyeGuide: A Tailored Glaucoma Behavior Change Program.Barriers to Attending Eye Appointments among Underserved Adults.Patient Attitudes Toward Telemedicine for Diabetic Retinopathy.Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.Systematic Review of Community-Engaged Research in Ophthalmology.Screening for vision-threatening diabetic retinopathy in South India: comparing portable non-mydriatic and standard fundus cameras and clinical exam.Predictors of Photographic Quality with a Handheld Nonmydriatic Fundus Camera Used for Screening of Vision-Threatening Diabetic Retinopathy.Personalized behavior change program for glaucoma patients with poor adherence: a pilot interventional cohort study with a pre-post designAssessing the Role of the Family/Support System Perspective in Patients With GlaucomaAccess to and Experiences with e-Health Technology Among Glaucoma Patients and Their Relationship with Medication AdherencePsychosocial Predictors of Glaucoma Medication Adherence among the Support, Educate, Empower (SEE) Personalized Glaucoma Coaching Pilot Study ParticipantsPreliminary Steps to Address Glaucoma Medication Adherence: Beginning to Tackle the Elephant in the RoomIntegrating Patient Education Into the Glaucoma Clinical Encounter: A Lean AnalysisCost-Utility Analysis of Glaucoma Medication AdherenceThe Debate Surrounding the Pathogenesis of MyopiaThe Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment StudySelf-reported Eye Care Use Among US Adults Aged 50 to 80 YearsMedication Adherence and Liquid Level Tracking System for Healthcare Provider Feedback
P50
Q27304671-3E14BD52-BFB5-4A81-97A6-5C3F8D06DFF4Q27304716-9E332E65-D704-4E2F-BA11-76E6DD04C320Q27345105-208D4632-D640-4296-BDAC-8D14909D6D5CQ30723404-AA0190EE-6E20-4089-9635-817827B6DC9EQ30749049-413F36F6-B3E9-4D84-ABE2-FB046C089B96Q33930485-57774ABF-0B9B-4EB6-B530-0C48D7FEC08CQ33944980-331C50F8-B18B-4508-BF03-0319829C7DB8Q33949700-D1F66DF4-7F8E-4566-81D7-A468169E4016Q34062494-A9FAF490-54D1-4C31-9BE7-79B71BC4154DQ34257625-AB808C6B-87BC-48B8-98DF-0C4DDDE47B00Q35229236-92CA87BD-7B07-471D-B1B9-4544622FA42DQ35956368-C384C8D2-7760-43E2-97DA-29A554B81CB9Q36282796-4EA47539-7CBE-4D74-86FB-51C60467F3FAQ36626069-F4F93C5F-F764-45AC-A1B0-EA398B0D85B9Q37711161-227093E5-B6A7-497E-AF50-0B7E223AB76BQ38997286-9178511A-8167-4B67-A686-36EBAF86CE7DQ39452154-F3E44666-85AE-4754-A193-2BDBF0564A51Q39902397-B8965037-0E01-4C7D-840E-1EADF943F9C8Q40159045-7F1D32DF-3E78-4934-B067-90906EBDBE15Q40874905-89C203CD-0EFC-418F-9B79-9BE47A9C963CQ41648189-751577B6-6446-4033-8C4E-FE958BDF236FQ45328650-A775AE2E-1B93-496E-93C1-85BFFC025DB7Q47761979-EF8C3560-A929-4E85-B56A-1FF89CE56C0CQ47852975-3BDD0E4F-45AF-4C1D-8CB7-18AF48762FA8Q50050163-8F6887ED-09D0-4EF6-A4F3-7424283346C4Q50081277-04937BEC-3D56-4F25-BE35-3D8826AFFBC4Q52938566-100442CD-A7E2-4F04-AF7B-0396E3B0813BQ56525913-932193AA-3E78-4157-84BB-A063EC78BE5AQ86652926-E21054E6-4C53-452D-9342-8011FC55E973Q88439330-9EE32B09-4E14-4884-B818-5B25EB5D9C1BQ89840847-1A82B6A9-C5F4-465B-8094-FA85D009F1CDQ90447342-3B50928D-7415-4E5F-BCFE-9D91B1364F21Q91036093-CD9A1D4C-9C2C-45B1-BBC6-E39628330F26Q91449557-EEBA7F62-DD74-42F1-B680-39FBBEDCFC13Q92401874-F35232F1-2DF7-428C-A989-EF8D47EBE750Q92606670-F6CC7228-EE66-46B1-87D1-2D56789B5BCEQ92897421-20D3BA62-5962-4CF1-AB9E-87FC14F48D78Q94449553-A9E05667-D066-4B49-96AA-9CF31ADF46D9
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Paula Anne Newman-Casey
@en
Paula Anne Newman-Casey
@nl
type
label
Paula Anne Newman-Casey
@en
Paula Anne Newman-Casey
@nl
prefLabel
Paula Anne Newman-Casey
@en
Paula Anne Newman-Casey
@nl
P31
P496
0000-0002-0847-1929